We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Hydralazine and Valproate Added to Chemotherapy for Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00395655
Recruitment Status : Terminated
First Posted : November 3, 2006
Last Update Posted : November 3, 2006
Sponsor:
Collaborators:
Information provided by: